Reardon, Sara (2023) Alzheimer’s drug trials plagued by lack of racial diversity. Nature, 620 (7973) Springer Science and Business Media LLC. 256-257 doi:10.1038/d41586-023-02464-1
| Reference Type | Journal (article/letter/editorial) | ||
|---|---|---|---|
| Title | Alzheimer’s drug trials plagued by lack of racial diversity | ||
| Journal | Nature | ||
| Authors | Reardon, Sara | Author | |
| Year | 2023 (August 10) | Volume | 620 |
| Issue | 7973 | ||
| Publisher | Springer Science and Business Media LLC | ||
| DOI | doi:10.1038/d41586-023-02464-1Search in ResearchGate | ||
| Generate Citation Formats | |||
| Mindat Ref. ID | 16645841 | Long-form Identifier | mindat:1:5:16645841:1 |
| GUID | 0 | ||
| Full Reference | Reardon, Sara (2023) Alzheimer’s drug trials plagued by lack of racial diversity. Nature, 620 (7973) Springer Science and Business Media LLC. 256-257 doi:10.1038/d41586-023-02464-1 | ||
| Plain Text | Reardon, Sara (2023) Alzheimer’s drug trials plagued by lack of racial diversity. Nature, 620 (7973) Springer Science and Business Media LLC. 256-257 doi:10.1038/d41586-023-02464-1 | ||
| In | (2023, August) Nature Vol. 620 (7973) Springer Science and Business Media LLC | ||
See Also
These are possibly similar items as determined by title/reference text matching only.
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|